ALZHEON, INC. — Form D/A

ALZHEON, INC. of FRAMINGHAM, MA, a company, filed a Form D amendment with the SEC on 2013-12-16. The offering totals $550K, of which $550K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (37)

Showing 25 of 37 people.

NameRoleLocation
ADAM HALE BROCKMANExecutive OfficerLEXINGTON, MA
JOHN ANTHONY HEYExecutive OfficerLEXINGTON, MA
GREGORY LEON MILLERExecutive OfficerLEXINGTON, MA
MARK YONGXIN VERSAVELExecutive OfficerLEXINGTON, MA
JEREMY YONGXIN YUExecutive OfficerLEXINGTON, MA
Menghis BairuDirectorSan Mateo, CA
Michael AcetiExecutive OfficerNeedham, MA
Dennis LangerDirectorNaples, FL
Diane K Jorkasky, M.D.DirectorFramingham, MA
Muneer E SatterDirectorFramingham, MA
Neil W FlanzraichDirectorFramingham, MA
Glenn E PaulyExecutive OfficerFramingham, MA
Susan K Abushakra, M.D.Executive OfficerFramingham, MA
John K Hey, Ph.D.Executive OfficerFramingham, MA
Kenneth A MaceExecutive OfficerFramingham, MA
Martin Tolar, M.D., Ph.D.DirectorFramingham, MA
Martin Tolar, M.D., Ph.D.Executive OfficerFramingham, MA
Gino K SantiniDirectorFramingham, MA
Christopher Noel DunnDirectorVancouver, A1
Adem E AlbayrakExecutive OfficerFramingham, MA
Jordan W HellerDirectorFramingham, MA
Aidan K Power, MRCPsychExecutive OfficerFramingham, MA
Muneer E SateerDirectorFramingham, MA
Robert SilvermanExecutive OfficerGreenville, SC
Scott MinickDirectorSunnyvale, CA

Other filings by this issuer (13)

FiledFormOfferingSold
2025-02-10D/A$150.0M$126.3M
2025-01-02D/A$125.0M$125.0M
2024-03-12D$50.0M$17.2M
2023-01-11D$50.0M$1.7M
2020-09-30D$50.0M$2.4M
2020-01-15D$6.2M$6.2M
2018-09-05D/A$19.8M$19.8M
2017-06-09D$15.8M$15.8M
2016-02-26D$5.0M$1.3M
2015-07-27D$6.9M$6.9M
2015-02-25D/A$7.3M
2015-01-09D$3.0M
2013-07-31D$550K$330K

More